Our mission

Our mission is to improve and innovate cancer screening programmes through high-quality clinical trials and studies focused on prevention, early diagnosis, and effective screening practices.

The CPTU’s primary objectives are to prevent cancer by detecting pre-cancerous lesions through well-designed clinical trials and studies, promote early cancer diagnosis by refining and advancing screening technologies, and to develop and evaluate cancer prevention strategies, including medicinal treatments with fewer side effects and behavioural interventions.

We work with a range of national and international collaborators to develop the evidence base for new and improved cancer prevention interventions, screening tests and early detection strategies. 



By optimising the efficacy and cost-effectiveness of screening programmes while minimising associated harms, we strive to advance stratified screening and better integrate population-wide screening with targeted early diagnosis.